Viewing Study NCT03943550


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-24 @ 5:03 PM
Study NCT ID: NCT03943550
Status: TERMINATED
Last Update Posted: 2024-02-15
First Post: 2019-05-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-05-13
Start Date Type: ACTUAL
Primary Completion Date: 2021-07-22
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-22
Completion Date Type: ACTUAL
First Submit Date: 2019-05-07
First Submit QC Date: None
Study First Post Date: 2019-05-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-07-21
Results First Submit QC Date: None
Results First Post Date: 2024-02-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-22
Last Update Post Date: 2024-02-15
Last Update Post Date Type: ACTUAL